510(k) K033884
K033884 is an FDA 510(k) premarket notification submitted by Randox Laboratories, Ltd. for the device "RANDOX AMIKACIN". The FDA issued a decision of Substantially Equivalent on Jun 9, 2004. The device falls under product code KLQ (Radioimmunoassay, Amikacin), a Class II device regulated under 21 CFR 862.3035. Randox Laboratories, Ltd. has 115 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 9, 2004
- Date Received
- Dec 15, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, Amikacin
- Device Class
- Class II
- Regulation Number
- 862.3035
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Randox Laboratories, Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.